Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Total Liabilities (2016 - 2017)

Bone Biologics has reported Total Liabilities over the past 3 years, most recently at $9.2 million for Q4 2017.

  • Quarterly Total Liabilities rose 1.4% to $9.2 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $9.2 million through Dec 2017, up 1.4% year-over-year, with the annual reading at $9.2 million for FY2017, 1.4% up from the prior year.
  • Total Liabilities was $9.2 million for Q4 2017 at Bone Biologics, down from $11.8 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $11.8 million in Q3 2017 and troughed at $7.2 million in Q4 2015.
  • The 3-year median for Total Liabilities is $9.1 million (2016), against an average of $8.9 million.
  • The largest YoY upside for Total Liabilities was 53.23% in 2017 against a maximum downside of 1.4% in 2017.
  • A 3-year view of Total Liabilities shows it stood at $7.2 million in 2015, then rose by 25.41% to $9.1 million in 2016, then increased by 1.4% to $9.2 million in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Total Liabilities are $9.2 million (Q4 2017), $11.8 million (Q3 2017), and $10.5 million (Q2 2017).